(Q43864747)

27 November 2017

title

Menopausal hormone therapy and risk of ovarian cancer in the European prospective investigation into cancer and nutrition (English)

1 reference

27 November 2017

1 reference

9

1 reference

27 November 2017

25

1 reference

27 November 2017

32

1 reference

27 November 2017

34

1 reference

27 November 2017

39

1 reference

27 November 2017

Bas Bueno-de-Mesquita

26

H Bas Bueno-de-Mesquita

1 reference

27 November 2017

18

Heiner Boeing

1 reference

Marie-Christine Boutron-Ruault

27 November 2017

15

Marie-Christine Boutron-Ruault

1 reference

27 November 2017

12

Anne Tjønneland

1 reference

27 November 2017

Agnès Fournier

8

0 references

Domenico Palli

Domenico Palli

Françoise Clavel-Chapelon

21

0 references

16

Francoise Clavel-Chapelon

1 reference

27 November 2017

5

Rudolf Kaaks

1 reference

27 November 2017

24

Rosario Tumino

1 reference

27 November 2017

10

Kim Overvad

1 reference

27 November 2017

37

Kay-Tee Khaw

1 reference

27 November 2017

36

Pilar Amiano

1 reference

27 November 2017

Vassiliki Benetou

20

0 references

Eva Ardanaz

35

Eva Ardanaz

1 reference

27 November 2017

7

Eiliv Lund

1 reference

27 November 2017

13

Sabina Rinaldi

1 reference

27 November 2017

17

Annekatrin Lukanova

1 reference

27 November 2017

14

Isabelle Romieu

1 reference

Fränzel J B van Duijnhoven

27 November 2017

27

Fränzel J B van Duijnhoven

1 reference

27 November 2017

19

Madlen Schütze

1 reference

27 November 2017

N Charlotte Onland-Moret

29

N Charlotte Onland-Moret

1 reference

27 November 2017

María José Sánchez Pérez

33

María-José Sánchez

1 reference

27 November 2017

30

Inger T Gram

1 reference

27 November 2017

4

Laure Dossus

1 reference

27 November 2017

Konstantinos K Tsilidis

1

Konstantinos K Tsilidis

1 reference

27 November 2017

38

Nick Wareham

1 reference

27 November 2017

31

Laudina Rodríguez

1 reference

27 November 2017

6

Kjersti Bakken

1 reference

27 November 2017

23

Rocco Galasso

1 reference

27 November 2017

28

Marieke G M Braem

1 reference

27 November 2017

Naomi E Allen

2

1 reference

27 November 2017

Timothy J Key

3

1 reference

27 November 2017

Louise Hansen

11

1 reference

27 November 2017

Franco Berrino

22

1 reference

27 November 2017

publication date

3 June 2011

1 reference

27 November 2017

published in

Cancer Causes & Control

1 reference

27 November 2017

volume

22

1 reference

27 November 2017

issue

8

1 reference

27 November 2017

page(s)

1075-1084

1 reference

Menopausal hormone therapy and risk of ovarian cancer: systematic review and meta-analysis

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9782-Z

Increased ovarian cancer risk associated with menopausal estrogen therapy is reduced by adding a progestin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9782-Z

European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9782-Z

Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer And Nutrition (EPIC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9782-Z

All progestins are not created equal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9782-Z

Hormone replacement therapy and incidence of hormone-dependent cancers in the Norwegian Women and Cancer study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9782-Z

Ovarian cancer and hormone replacement therapy in the Million Women Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9782-Z

A prospective study of postmenopausal hormone use and ovarian cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9782-Z

Hormone therapy and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9782-Z

Hormone replacement therapy and risk of epithelial ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9782-Z

Menopausal hormone therapy and risk of epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9782-Z

Hormone replacement therapy formulations and risk of epithelial ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9782-Z

Hormone therapy and ovarian cancer: incidence and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9782-Z

Hormonal factors and the risk of invasive ovarian cancer: a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9782-Z

Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9782-Z

Epidemiology of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9782-Z

Risk Factors for Invasive Epithelial Ovarian Cancer: Results from a Swedish Case-Control Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9782-Z

Estrogens and epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9782-Z

Expression of human estrogen receptor-alpha and -beta, progesterone receptor, and androgen receptor mRNA in normal and malignant ovarian epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9782-Z

Estrogen-induced loss of progesterone receptor expression in normal and malignant ovarian surface epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9782-Z

Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9782-Z

Comparison of patient recall of hormone therapy with physician records

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9782-Z

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9782-Z

Hormone Therapy and the Impact of Estrogen Intake on the Risk of Ovarian Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9782-Z

10.1007/S10552-011-9782-Z

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

27 November 2017

1040965947

0 references

1 reference